Cancer Survivors and Providers Differ on Cannabis Risk Awareness and Communication
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CancerResearchSafetyMental HealthPainAnxietyPolicy Why This Matters Clinicians treating cancer survivors need to…
The cannabis communication gap between cancer patients, providers: 5 notes
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. CancerSafetyPainAnxietyResearchMental HealthDosing Why This Matters Cancer patients frequently use or consider…
Cancer survivors and providers differ in views on medical cannabis, study finds
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CancerResearchPainSafetyPolicyAnxietyMental Health Why This Matters This study highlights a significant gap between…
Georgia’s medical cannabis program expands access | 11alive.com
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyPainAnxietyMental HealthNeurologySleepCancer Why This Matters Georgia's expanded medical cannabis program…
Cancer survivors and providers differ in views on medical cannabis, study finds
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. CancerResearchPainAnxietyMental HealthSafetyPolicy Why This Matters Clinicians need to understand that cancer…
Medicinal cannabis: Practical prescribing, safety and pathways
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PainSafetyDosingAgingCancerNeurologyMental Health Clinical Summary This article provides practical guidance on medicinal…
German Patients Fight Back Against Medical Cannabis Insurance Cuts ⚖️
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyPainMental HealthSafetyAnxietyCancerNeurology Why This Matters German patients challenging insurance coverage cuts…
Daily Cannabis News Brief for 7/21/2026
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CancerResearchCBDHempSafetyDosingNeurology Why This Matters Laboratory evidence that CBD, CBG, and CBN demonstrate…
Ananda Pharma Doses First Patient in NIHR-Backed CIPN Trial
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PainCancerNeurologyResearchDosingSafetyIndustry Why This Matters This trial represents a rigorous clinical pathway…
Cancer survivors and providers differ in views on medical cannabis, study finds
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CancerPainAnxietyResearchPolicySafetyMental Health Why This Matters Cancer survivors are increasingly using cannabis to…